Amphastar Pharmaceuticals AMPH Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $170.94M-6.5% | $170.18M+12.2% | $216.27M+12.6% | $187.69M-1.0% | $182.78M-9.1% | ||
| $121.01M+124% | $112.64M+60.8% | $59.94M+2.7% | $44.06M+56.5% | $54.1M-38.8% | ||
| $235K0.0% | $235K0.0% | $235K0.0% | $235K0.0% | $235K0.0% | ||
| $147.85M+2.2% | $143.56M+5.3% | $146.81M+5.1% | $132.98M+1.2% | $144.64M+4.7% | ||
| $170.19M-8.2% | $176.89M+15.1% | $185.93M+42.7% | $191.73M+56.6% | $185.48M+60.6% | ||
| $11.65M-34.5% | $13.15M-27.8% | $26.02M+46.8% | $20.33M+156% | $17.77M+104% | ||
| $633.68M+7.8% | $636.02M+19.1% | $639.47M+17.1% | $580.83M+20.3% | $587.96M+5.9% | ||
| $307.23M-0.1% | $310.57M+4.4% | $308.69M+4.5% | $310.24M+7.7% | $307.6M+6.6% | ||
| $71.5M+56.0% | $42.93M-8.5% | $44.58M+40.6% | $44.2M+37.7% | $45.82M+46.2% | ||
| $559.62M-4.3% | $565.97M-4.2% | $572.24M-3.8% | $578.5M-3.7% | $584.53M-3.7% | ||
| $33.48M+45.6% | $31.14M+19.8% | $29.87M+26.2% | $28.1M+15.8% | $22.99M-1.6% | ||
| $1.65B+1.3% | $1.63B+3.3% | $1.67B+7.8% | $1.62B+8.3% | $1.63B+3.3% | ||
| $152.69M-13.2% | $148.35M-5.5% | $190.84M+24.5% | $166.55M+26.9% | $175.94M+50.8% | ||
| $1.67M+646% | $1.64M+601% | $923K+266% | $927K+272% | $224K-47.7% | ||
| $9.71M+25.3% | $7.93M+16.5% | $7.83M+86.0% | $7.88M+97.2% | $7.75M+96.5% | ||
| $164.48M-17.4% | $158.16M-9.0% | $205.23M+29.1% | $176.41M+28.8% | $199.05M-22.0% | ||
| $609.8M+1.0% | $608.75M+1.2% | $608.58M+2.0% | $607.73M+3.6% | $603.86M+1.7% | ||
| $65.2M+60.2% | $37.68M-10.0% | $39.44M+36.3% | $38.96M+32.2% | $40.71M+41.6% | ||
| —— | —— | —— | —— | —— | ||
| $232K-39.3% | $264K-38.9% | $301K-37.9% | $345K-34.4% | $382K-32.0% | ||
| $29.37M+20.2% | $29.98M+43.1% | $29.27M+8.3% | $27.8M+47.8% | $24.42M+35.8% | ||
| $874.77M0.0% | $840.49M-0.6% | $889.48M+8.8% | $857.85M+10.2% | $874.99M-3.0% | ||
| $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | ||
| $543.82M+6.8% | $535.38M+5.9% | $527.22M+6.2% | $520.58M+6.8% | $509.11M+6.9% | ||
| $673.3M+13.3% | $666.88M+17.2% | $642.45M+21.0% | $625.1M+27.5% | $594.07M+31.3% | ||
| -$5.74M+28.0% | -$5.31M+42.1% | -$5.27M+40.2% | -$5.36M+39.3% | -$7.97M+9.1% | ||
| $438M+27.3% | $408.15M+22.7% | $387.65M+33.3% | $382.85M+49.7% | $343.93M+39.0% | ||
| $1.65B+1.3% | $1.63B+3.3% | $1.67B+7.8% | $1.62B+8.3% | $1.63B+3.3% | ||
| $9.61M+1,167% | $17.17M+883% | $2.07M-61.4% | $1.6M+140% | $758K-3.3% | ||
| $2.2M0.0% | $2.2M0.0% | $2.2M0.0% | $2.2M0.0% | $2.2M0.0% | ||
| $33.48M+45.6% | $31.14M+19.8% | $29.87M+26.2% | $28.1M+15.8% | $22.99M-1.6% | ||
| $559.62M-4.3% | $565.97M-4.2% | $572.24M-3.8% | $578.5M-3.7% | $584.53M-3.7% | ||
| $71.5M+56.0% | $42.93M-8.5% | $44.58M+40.6% | $44.2M+37.7% | $45.82M+46.2% | ||
| $42.46M-40.3% | $42.46M-40.3% | $71.12M+33.6% | $71.12M+33.6% | $71.12M+33.6% | ||
| $559.62M-4.3% | $565.97M-4.2% | $572.24M-3.8% | $578.5M-3.7% | $584.53M-3.7% | ||
| $71.5M+56.0% | $42.93M-8.5% | $44.58M+40.6% | $44.2M+37.7% | $45.82M+46.2% | ||
| $33.48M+45.6% | $31.14M+19.8% | $29.87M+26.2% | $28.1M+15.8% | $22.99M-1.6% | ||
| $121.01M+124% | $112.64M+60.8% | $59.94M+2.7% | $44.06M+56.5% | $54.1M-38.8% | ||
| $71.5M+56.0% | $42.93M-8.5% | $44.58M+40.6% | $44.2M+37.7% | $45.82M+46.2% | ||
| $33.48M+45.6% | $31.14M+19.8% | $29.87M+26.2% | $28.1M+15.8% | $22.99M-1.6% | ||
| $152.69M-13.2% | $148.35M-5.5% | $190.84M+24.5% | $166.55M+26.9% | $175.94M+50.8% | ||
| $414K-97.3% | $239K-97.5% | $5.63M+340% | $1.05M-30.7% | $15.14M+159% | ||
| $1.67M+646% | $1.64M+601% | $923K+266% | $927K+272% | $224K-47.7% | ||
| $609.8M+1.0% | $608.75M+1.2% | $608.58M+2.0% | $607.73M+3.6% | $603.86M+1.7% | ||
| $686.61M+5.2% | $656.27M+0.8% | $657.07M+4.2% | $655.84M+5.6% | $652.92M+4.0% | ||
| $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | ||
| $438M+27.3% | $408.15M+22.7% | $387.65M+33.3% | $382.85M+49.7% | $343.93M+39.0% | ||
| $5.93M-14.8% | $5.93M-14.8% | $6.96M+14.7% | $6.96M+14.7% | $6.96M+14.7% | ||
| $185K-44.8% | $221K-42.3% | $259K-39.2% | $296K-36.9% | $335K-35.1% | ||
| $609.8M+1.0% | $608.75M+1.2% | $608.58M+2.0% | $607.73M+3.6% | $603.86M+1.7% | ||
| $1.67M+646% | $1.64M+601% | $923K+266% | $927K+272% | $224K-47.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Amphastar Pharmaceuticals's total assets?
- Amphastar Pharmaceuticals (AMPH) holds $1.6B in total assets, up 1.4% year over year.
- How much cash does Amphastar Pharmaceuticals have?
- Amphastar Pharmaceuticals holds $170.9M in cash and equivalents.
- Can Amphastar Pharmaceuticals cover its short-term obligations?
- Its current ratio is 3.85 — current assets exceed current liabilities.
- Where does Amphastar Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Amphastar Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
